| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jaguar Health, Inc. (JAGX) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. JAGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.3K | $98.6K | - | |
| Other | 11.9K | $40.2K | - | |
| Other | 11.9K | $40.2K | - | |
| CFO | 11.9K | $40.1K | - | |
| Other | 11.7K | $39.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | Wolin Jonathan S. | Chief Of Staff, CCO &GC | Buy | 317 | $0.03 | $9.51 | +4.8% | -90.4% | -97.7% | |
| Sep 13, 2021 | Lizak Carol R. | Chief Financial Officer | Buy | 7,968 | $2.51 | $19,999.68 | New | -51.6% | -90.5% | |
| Sep 13, 2021 | Conte Lisa A | CEO And President | Buy | 7,968 | $2.51 | $19,999.68 | +22,766% | -51.6% | -90.5% | |
| Jun 4, 2021 | Bochnowski James J | Director | Sell | 444 | $1.75 | $775.48 | - | -32.2% | -93.5% | |
| Jul 23, 2019 | Siegel Jonathan B. | Director | Buy | 12,705 | $2.00 | $25,410.00 | +2,225% | - | - | |
| Jul 23, 2019 | Bochnowski James J | Director | Buy | 180,582 | $2.00 | $361,164.00 | +17,431% | - | - | |
| Oct 4, 2018 | Siegel Jonathan B. | Director | Buy | 25,000 | $0.60 | $15,000.00 | +166.7% | - | - | |
| Jul 18, 2018 | Conte Lisa A | CEO And President | Buy | 1,500 | $1.11 | $1,668.60 | +25.0% | - | - | |
| Jul 18, 2018 | Siegel Jonathan B. | Director | Buy | 5,000 | $1.10 | $5,476.00 | +51.4% | - | - | |
| Jul 17, 2018 | Siegel Jonathan B. | Director | Buy | 9,732 | $1.32 | $12,845.58 | +100.0% | - | - |